Bryan 國三上 (2014/04/19) Selegiline has greater affinity for type B rather than for type A active sites, it can serve as a selective inhibitor of MAO type B if it is administered at the recommended dose. Dopaminergic antiparkinsonism agents Monoamine oxidase inhibitors (MAOIs)